Author : Danylenko V.V.
Radionuclide monitoring and diagnostic algorithm for detection of relevance and metastasis in patients with iodine-negative forms of differentiated thyroid cancerAuthors: Solodiannykova O.I. Danylenko V.V. Bankovska N.V. Дата: 2026-05-27
Treatment with tyrosine kinase inhibitors in patients with metastatic differentiated thyroid cancer refractory to radioiodine therapyAuthors: Solodiannykova O.I. Danylenko V.V. Т. 15, №4 (60)
Side effects of iodine-negative thyroid cancer targeted therapyAuthors: Solodyannikova O.I. Bankovska N.V. Danylenko V.V. Turitsyna V.L. Т. 15, №1 (57)
Sorafenib in the treatment of iodine-negative differentiated thyroid cancerAuthors: Solodiannykova O.I. Kmetyuk Y.V. Stolyarova O.Yu. Danylenko V.V.... Т. 14, №2 (54)
Formation of radioiodine resistance in patients with differentiated thyroid cancer and possibilities of its prediction. Data from own research and literature were usedAuthors: Solodyannуkova O.I. Zelinskaya A.V. Danylenko V.V. Т. 13, № 2 (50)
Metastatic bone lesions: molecular mechanisms as new avenues of therapeutic influence. Literature reviewAuthors: Solodyannуkova O.I. Bankovska N.V. Shypko A.F. Danylenko V.V.... Т. 13, № 1 (49)
Comparative analysis of the use of radiopharmaceuticals in the treatment of bone metastasesAuthors: Solodyannуkova O.I. Danylenko V.V. Т. 12, № 3-4 (47-48)
